Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin

NCT03804983 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DEVICE: Hybrid Closed Loop (HCL)
DEVICE: Control-IQ with MyTDI

Sponsor

University of Virginia

Collaborators

[object Object]
[object Object]